SCHEMBL26419252

SCHEMBL26419252

NC(=O)c1cn(C2CCNCC2)nc1Cl

nearest known ligand 0.44

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
IRAK4 Q9NWZ3 2/20 0.44
PARP1 P09874 7/20 0.41
PARP2 Q9UGN5 4/20 0.41
BTK Q06187 1/20 0.40
PARP3 Q9Y6F1 2/20 0.40
PIM1 P11309 4/20 0.39
PIM2 Q9P1W9 4/20 0.39
PIM3 Q86V86 2/20 0.39
PAK1 Q13153 1/20 0.38
JAK1 P23458 2/20 0.37
JAK3 P52333 1/20 0.37
TTK P33981 1/20 0.37
JAK2 O60674 1/20 0.37
TYK2 P29597 1/20 0.37
PAK4 O96013 1/20 0.36
PKN1 Q16512 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28240637 0.86 BTK (0.51) BTKJAK1JAK2TYK2
SCHEMBL31226866 0.84 IRAK4 (0.49) IRAK4PARP1PARP2BTKPARP3
SCHEMBL27758269 0.74 NOTUM (0.38) IRAK4BTKJAK1JAK2TYK2
SCHEMBL3069502 0.74 LRRK2 (0.35) BTKJAK1JAK2TYK2
SCHEMBL28184239 0.74 PARP1 (0.61) IRAK4PARP1PARP2PARP3
SCHEMBL31561223 0.73 BTK (0.43) IRAK4BTKPAK1JAK1JAK2
SCHEMBL23178439 0.73 TLR8 (0.44)
SCHEMBL30158029 0.73 PARP2 (0.51) IRAK4PARP1PARP2PARP3
SCHEMBL28863344 0.72 BTK (0.43) BTKJAK1JAK2
SCHEMBL27758258 0.72 BTK (0.40) IRAK4BTK

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023192901-A9 QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS ESCIENT PHARMACEUTICALS, INC. (US) 2023-12-14 WO disclosed
WO-2023192901-A1 QUINOLINE DERIVATIVES AS MODULATORS OF MAS-RELATED G-PROTEIN RECEPTOR X2 AND RELATED PRODUCTS ESCIENT PHARMACEUTICALS, INC. (US) 2023-10-05 WO disclosed